Clinical development is facing growing pressure from increasing trial complexity, talent shortages, rising costs, and demands for faster outcomes.
The Agentic CRO Blueprint explores how CROs and sponsors can leverage an AI Workforce to modernize trial execution, improve operational efficiency, and scale without relying solely on headcount growth.
Download the blueprint and discover how leading organizations are preparing for the next generation of clinical trial execution.
Founder & CEO, Maxis AI
Moulik Shah has been at the forefront of leveraging technology to transform pharmaceutical and life sciences clinical trials for over 20 years. A passionate healthcare technology entrepreneur Moulik’s dedication to improving clinical outcomes has fueled his vision of an integrated healthcare ecosystem based on effective use of data and analytics platforms. Moulik has been instrumental in driving innovation and progress in the industry. Under his leadership, Maxis AI has become a leading provider of clinical data and analytics, driving real-world impact in the pharmaceutical and life sciences clinical trials.